CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Neuronetics - STIM CFD

    1.80
    3.41%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.12
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026207 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026207%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003985 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003985%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Neuronetics Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 1.76
    Open* 1.76
    1-Year Change* -71.75%
    Day's Range* 1.74 - 1.85
    52 wk Range 1.03-6.95
    Average Volume (10 days) 32.19K
    Average Volume (3 months) 1.71M
    Market Cap 38.19M
    P/E Ratio -100.00K
    Shares Outstanding 28.93M
    Revenue 69.23M
    EPS -1.18
    Dividend (Yield %) N/A
    Beta 1.84
    Next Earnings Date Mar 5, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 7, 2023 1.76 -0.02 -1.12% 1.78 1.84 1.75
    Dec 6, 2023 1.85 -0.08 -4.15% 1.93 1.96 1.83
    Dec 5, 2023 1.93 -0.23 -10.65% 2.16 2.20 1.90
    Dec 4, 2023 2.18 0.20 10.10% 1.98 2.18 1.97
    Dec 1, 2023 1.98 0.14 7.61% 1.84 2.01 1.79
    Nov 30, 2023 1.76 0.28 18.92% 1.48 1.84 1.48
    Nov 29, 2023 1.48 0.11 8.03% 1.37 1.54 1.36
    Nov 28, 2023 1.36 -0.02 -1.45% 1.38 1.40 1.35
    Nov 27, 2023 1.40 0.02 1.45% 1.38 1.43 1.37
    Nov 24, 2023 1.38 0.07 5.34% 1.31 1.38 1.30
    Nov 22, 2023 1.28 -0.02 -1.54% 1.30 1.31 1.28
    Nov 21, 2023 1.30 -0.02 -1.52% 1.32 1.32 1.28
    Nov 20, 2023 1.32 0.03 2.33% 1.29 1.33 1.29
    Nov 17, 2023 1.32 -0.02 -1.49% 1.34 1.34 1.28
    Nov 16, 2023 1.33 0.02 1.53% 1.31 1.38 1.31
    Nov 15, 2023 1.33 -0.01 -0.75% 1.34 1.38 1.33
    Nov 14, 2023 1.35 0.12 9.76% 1.23 1.38 1.23
    Nov 13, 2023 1.22 -0.01 -0.81% 1.23 1.26 1.20
    Nov 10, 2023 1.24 -0.04 -3.13% 1.28 1.28 1.20
    Nov 9, 2023 1.27 -0.11 -7.97% 1.38 1.38 1.22

    Neuronetics Events

    Time (UTC) Country Event
    Tuesday, March 5, 2024

    Time (UTC)

    13:30

    Country

    US

    Event

    Q4 2023 Neuronetics Inc Earnings Release
    Q4 2023 Neuronetics Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 65.206 55.312 49.244 62.656 52.776
    Revenue 65.206 55.312 49.244 62.656 52.776
    Cost of Revenue, Total 15.483 11.653 11.554 15.389 12.447
    Gross Profit 49.723 43.659 37.69 47.267 40.329
    Total Operating Expense 100.317 82.876 72.477 89.586 72.61
    Selling/General/Admin. Expenses, Total 75.498 63.3 50.798 60.45 51.931
    Research & Development 9.336 7.923 9.201 13.747 8.232
    Operating Income -35.111 -27.564 -23.233 -26.93 -19.834
    Interest Income (Expense), Net Non-Operating -3.251 -3.819 -4.522 -3.685 -3.688
    Other, Net 1.203 0.19 0.302 1.571 -0.575
    Net Income Before Taxes -37.159 -31.193 -27.453 -29.044 -24.097
    Net Income After Taxes -37.159 -31.193 -27.453 -29.044 -24.097
    Net Income Before Extra. Items -37.159 -31.193 -27.453 -29.044 -24.097
    Net Income -37.159 -31.193 -27.453 -29.044 -24.097
    Income Available to Common Excl. Extra. Items -37.159 -31.193 -27.453 -29.044 -24.097
    Income Available to Common Incl. Extra. Items -37.159 -31.193 -27.453 -29.044 -24.097
    Diluted Net Income -37.159 -31.193 -27.453 -29.044 -24.097
    Diluted Weighted Average Shares 26.9 25.479 18.835 18.38 8.948
    Diluted EPS Excluding Extraordinary Items -1.38138 -1.22426 -1.45755 -1.5802 -2.693
    Dividends per Share - Common Stock Primary Issue
    Diluted Normalized EPS -1.36279 -1.17324 -1.40849 -1.5802 -2.693
    Unusual Expense (Income) 0 0 0.924
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 17.61 15.54 18.198 16.498 16.329
    Revenue 17.61 15.54 18.198 16.498 16.329
    Cost of Revenue, Total 4.836 4.144 4.39 3.57 4.039
    Gross Profit 12.774 11.396 13.808 12.928 12.29
    Total Operating Expense 24.959 25.447 25.925 23.952 26.125
    Selling/General/Admin. Expenses, Total 17.759 18.513 18.396 18.034 19.941
    Research & Development 2.364 2.79 3.139 2.348 2.045
    Unusual Expense (Income) 0 0 0.1
    Operating Income -7.349 -9.907 -7.727 -7.454 -9.796
    Interest Income (Expense), Net Non-Operating -1.144 -1.253 -1.212 -1.061 -1
    Other, Net 3.592 0.64 0.649 0.906 0.374
    Net Income Before Taxes -4.901 -10.52 -8.29 -7.609 -10.422
    Net Income After Taxes -4.901 -10.52 -8.29 -7.609 -10.422
    Net Income Before Extra. Items -4.901 -10.52 -8.29 -7.609 -10.422
    Net Income -4.901 -10.52 -8.29 -7.609 -10.422
    Income Available to Common Excl. Extra. Items -4.901 -10.52 -8.29 -7.609 -10.422
    Income Available to Common Incl. Extra. Items -4.901 -10.52 -8.29 -7.609 -10.422
    Diluted Net Income -4.901 -10.52 -8.29 -7.609 -10.422
    Diluted Weighted Average Shares 28.59 28.034 27.209 26.965 26.787
    Diluted EPS Excluding Extraordinary Items -0.17142 -0.37526 -0.30468 -0.28218 -0.38907
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.17142 -0.37526 -0.301 -0.27847 -0.37787
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 98.769 115.331 65.012 88.451 114.473
    Cash and Short Term Investments 70.34 94.141 48.957 75.708 104.583
    Cash & Equivalents 70.34 94.141 48.957 75.708 104.583
    Total Receivables, Net 15.359 9.978 9.053 7.449 5.62
    Accounts Receivable - Trade, Net 13.591 7.706 7.166 6.569 5.62
    Total Inventory 8.899 6.563 3.72 2.775 2.432
    Prepaid Expenses 4.171 4.649 3.282 2.519 1.838
    Total Assets 116.884 141.223 78.657 100.168 117.022
    Property/Plant/Equipment, Total - Net 5.318 5.104 5.348 4.903 1.378
    Property/Plant/Equipment, Total - Gross 8.375 7.641 7.752 7.11 3.394
    Accumulated Depreciation, Total -3.057 -2.537 -2.404 -2.207 -2.016
    Other Long Term Assets, Total 11.213 8.981 5.966 5.084 1.171
    Total Current Liabilities 33.199 15.703 13.682 27.693 13.559
    Accounts Payable 2.433 4.299 3.749 4.625 3.756
    Accrued Expenses 14.861 7.923 7.309 9.03 7.055
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 13.125 0 0 11.25
    Other Current Liabilities, Total 2.78 3.481 2.624 2.788 2.748
    Total Liabilities 59.824 56.048 53.164 52.316 45.98
    Total Long Term Debt 22.829 35.335 34.62 19.898 30.395
    Long Term Debt 22.829 35.335 34.62 19.898 30.395
    Other Liabilities, Total 3.796 5.01 4.862 4.725 2.026
    Total Equity 57.06 85.175 25.493 47.852 71.042
    Redeemable Preferred Stock 0 0 0 0 0
    Common Stock 0.273 0.264 0.191 0.186 0.177
    Additional Paid-In Capital 402.679 393.644 302.842 297.753 291.908
    Retained Earnings (Accumulated Deficit) -345.892 -308.733 -277.54 -250.087 -221.043
    Total Liabilities & Shareholders’ Equity 116.884 141.223 78.657 100.168 117.022
    Total Common Shares Outstanding 27.268 26.395 19.114 18.645 17.744
    Note Receivable - Long Term 1.584 11.807 2.331 1.73
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 71.011 77.676 81.107 98.769 101.096
    Cash and Short Term Investments 35.847 45.905 55.443 70.34 73.698
    Cash & Equivalents 35.847 45.905 55.443 70.34 73.698
    Total Receivables, Net 17.842 16.192 12.207 15.359 13.917
    Accounts Receivable - Trade, Net 15.024 13.145 9.452 13.591 11.963
    Total Inventory 9.737 8.871 9.142 8.899 8.573
    Prepaid Expenses 7.585 6.708 4.315 4.171 4.908
    Total Assets 92.988 100.392 103.604 116.884 119.235
    Property/Plant/Equipment, Total - Net 4.982 5.164 5.183 5.318 5.568
    Property/Plant/Equipment, Total - Gross 8.527 8.534 8.389 8.375 8.485
    Accumulated Depreciation, Total -3.545 -3.37 -3.206 -3.057 -2.917
    Note Receivable - Long Term 4.891 5.53 6.178 1.584 1.711
    Other Long Term Assets, Total 12.104 12.022 11.136 11.213 10.86
    Total Current Liabilities 15.336 15.026 15.13 33.199 25.143
    Accounts Payable 2.822 4.143 4.97 2.433 2.35
    Accrued Expenses 10.024 8.45 7.568 14.861 11.378
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 0 0 13.125 8.75
    Other Current Liabilities, Total 2.49 2.433 2.592 2.78 2.665
    Total Liabilities 55.047 54.915 55.259 59.824 56.244
    Total Long Term Debt 36.851 36.713 36.641 22.829 27.009
    Long Term Debt 36.851 36.713 36.641 22.829 27.009
    Other Liabilities, Total 2.86 3.176 3.488 3.796 4.092
    Total Equity 37.941 45.477 48.345 57.06 62.991
    Redeemable Preferred Stock 0 0 0
    Common Stock 0.289 0.288 0.285 0.273 0.27
    Additional Paid-In Capital 408.356 406.502 404.472 402.679 400.323
    Retained Earnings (Accumulated Deficit) -370.704 -361.313 -356.412 -345.892 -337.602
    Total Liabilities & Shareholders’ Equity 92.988 100.392 103.604 116.884 119.235
    Total Common Shares Outstanding 28.902 28.813 28.465 27.268 27.06
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -37.159 -31.193 -27.453 -29.044 -24.097
    Cash From Operating Activities -30.739 -27.983 -28.39 -30.482 -20.591
    Cash From Operating Activities 1.648 1.06 0.941 1.065 0.882
    Non-Cash Items 9.547 8.787 6.397 4.41 4.207
    Cash Interest Paid 3.543 3.304 3.892 2.949 2.786
    Changes in Working Capital -4.775 -6.637 -8.275 -6.913 -1.583
    Cash From Investing Activities 6.731 -9.839 -0.73 -0.813 -1.011
    Capital Expenditures -3.269 -2.353 -0.73 -0.813 -1.011
    Cash From Financing Activities 0.207 83.006 2.369 2.42 97.038
    Financing Cash Flow Items -0.091 -0.401 -0.821 0 -3.463
    Issuance (Retirement) of Stock, Net 0.298 83.407 0.69 2.42 100.501
    Issuance (Retirement) of Debt, Net 0 0 2.5 0 0
    Net Change in Cash -23.801 45.184 -26.751 -28.875 75.436
    Other Investing Cash Flow Items, Total 10 -7.486
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -10.52 -37.159 -28.869 -21.26 -10.838
    Cash From Operating Activities -15.213 -30.739 -27.639 -21.132 -12.182
    Cash From Operating Activities 0.516 1.648 1.044 0.657 0.319
    Non-Cash Items 1.993 9.547 7.238 4.887 2.416
    Cash Interest Paid 1.064 3.543 2.525 1.638 0.814
    Changes in Working Capital -7.202 -4.775 -7.052 -5.416 -4.079
    Cash From Investing Activities -0.183 6.731 7.234 -2.04 -1.074
    Capital Expenditures -0.234 -3.269 -2.766 -2.04 -1.074
    Cash From Financing Activities 0.499 0.207 -0.038 -0.038 -0.048
    Financing Cash Flow Items -0.801 -0.091 -0.09 -0.09 -0.057
    Issuance (Retirement) of Stock, Net 0 0.298 0.052 0.052 0.009
    Issuance (Retirement) of Debt, Net 1.3 0
    Net Change in Cash -14.897 -23.801 -20.443 -23.21 -13.304
    Other Investing Cash Flow Items, Total 0.051 10 10
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Archon Capital Management LLC Hedge Fund 9.9666 2877706 428949 2023-08-14 MED
    Cannell Capital, LLC Hedge Fund 9.7968 2828655 388119 2023-09-05 LOW
    Kent Lake Capital LLC Hedge Fund 5.5418 1600100 893751 2023-09-12 HIGH
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 4.6865 1353144 0 2023-06-30 LOW
    Balyasny Asset Management LP Hedge Fund 4.4905 1296555 373217 2023-06-30 HIGH
    Silvercrest Asset Management Group LLC Investment Advisor/Hedge Fund 3.9117 1129430 159439 2023-06-30 LOW
    Schroder Investment Management North America Inc. Investment Advisor 3.2725 944880 42095 2023-06-30 LOW
    Parian Global Management LP Hedge Fund 2.6336 760410 -69863 2022-12-31
    Medical Strategy GmbH Investment Advisor 2.579 744647 50847 2023-03-31 MED
    First Eagle Investment Management, L.L.C. Investment Advisor/Hedge Fund 2.0094 580175 61786 2023-06-30 LOW
    Sullivan (Keith J) Individual Investor 1.7884 516373 -19540 2023-07-21 MED
    Brandywine Global Investment Management, LLC Investment Advisor 1.7386 501985 -2200 2023-06-30 LOW
    First Washington Corporation Investment Advisor 1.719 496345 0 2023-06-30
    Acadian Asset Management LLC Investment Advisor/Hedge Fund 1.4603 421626 6136 2023-06-30 MED
    Millrace Asset Group, Inc. Hedge Fund 1.3546 391123 -244084 2023-06-30 HIGH
    BlackRock Institutional Trust Company, N.A. Investment Advisor 1.3127 379010 5117 2023-06-30 LOW
    Renaissance Technologies LLC Hedge Fund 1.2929 373300 75900 2023-06-30 HIGH
    Dafna Capital Management, LLC Hedge Fund 1.0865 313717 0 2023-06-30 LOW
    Two Sigma Investments, LP Hedge Fund 1.0649 307485 -69949 2023-06-30 HIGH
    Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.9872 285051 -88995 2023-06-30 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Neuronetics Company profile

    About Neuronetics Inc

    Neuronetics, Inc. is a commercial-stage medical technology company. The Company is focused on designing, developing, and marketing products to treat psychiatric disorders. Its primary product includes NeuroStar Advanced Therapy System, which is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation (TMS), to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The NeuroStar Advanced Therapy System is used to treat depressive disorder. The Company sells NeuroStar Advanced Therapy System and recurring treatment Sessions in the United States.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, Neuronetics Inc revenues increased 12% to $55.3M. Net loss increased 14% to $31.2M. Revenues reflect United States segment increase of 12% to $53.4M, International segment increase of 8% to $1.9M. Higher net loss reflects Sales and marketing - Balancing value increase of 16% to $35.7M (expense), General and administrative - Balancing increase of 24% to $20.1M (expense).

    Industry: Advanced Medical Equipment & Technology (NEC)

    3222 Phoenixville Pike
    MALVERN
    PENNSYLVANIA 19355
    US

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    Gold

    2,002.58 Price
    -1.240% 1D Chg, %
    Long position overnight fee -0.0198%
    Short position overnight fee 0.0116%
    Overnight fee time 22:00 (UTC)
    Spread 0.50

    XRP/USD

    0.67 Price
    +3.060% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    BTC/USD

    43,892.20 Price
    +0.980% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    US100

    16,013.30 Price
    +0.120% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading